FDA catalysts, PDUFA dates with approval probability, drug pipeline, cash runway and insider activity — updated automatically from SEC, FDA and ClinicalTrials.gov data.
| Date | Drug | Type | Run-up 30d | Decision 1d | After 5d |
|---|---|---|---|---|---|
| 2026-03-17 | — | NDA | -19.4% | -70.7% | -47.3% |
| 2026-03-16 | — | NDA | -22.5% | +2.6% | -56.1% |
| 2025-12-16 | — | NDA | -20.5% | +33.1% | +38.9% |
A free BioRadar account adds AI daily briefings, sentiment tracking, trial enrollment progress, and email alerts for ALDX and 2 more tickers of your choice.
Create Free Account →